| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 9 |
| 1 | PANITUMUMAB | 9 |
| 2 | BEVACIZUMAB | 8 |
| 3 | FLUOROURACIL | 7 |
| 4 | FLUOROURACIL CREAM, 0.5% | 7 |
| 5 | DEXAMETHASONE | 5 |
| 6 | DEXAMETHASONE 1.5 MG | 5 |
| 7 | FRUQUINTINIB | 5 |
| 8 | CAPECITABINE | 4 |
| 9 | FILGRASTIM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FRUQUINTINIB | 5 | 0.0013 |
| 1 | ZIV-AFLIBERCEPT | 1 | 0.0008 |
| 2 | PANITUMUMAB | 9 | 0.0006 |
| 3 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 4 | GLYCERIN SUPPOSITORY | 1 | 0.0004 |
| 5 | GLYCERIN SUPPOSITORIES | 1 | 0.0004 |
| 6 | DALTEPARIN SODIUM | 3 | 0.0003 |
| 7 | BEVACIZUMAB-AWWB | 1 | 0.0002 |
| 8 | REGORAFENIB | 2 | 0.0002 |
| 9 | LAMIVUDINE | 4 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 10 | 0.0002 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 5 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 9 | 0.0000 |
| 7 | Bile Acid [EPC] | 1 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 10 | 0.0000 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0000 |